An adenosine analog (IB-MECA) inhibits anchorage-dependent cell growth of various human breast cancer cell lines |
| |
Authors: | Panjehpour Mojtaba Karami-Tehrani Fatemeh |
| |
Affiliation: | Department of Clinical Biochemistry, School of Medical Sciences, Tarbiat Modarres University, P.O. Box 14115-111, Tehran, Iran. |
| |
Abstract: | A3 adenosine receptor agonists have been reported to influence cell death and survival. Here we report the effects of an A3 adenosine receptor agonist, IB-MECA, on the cell growth of human breast cancer cell lines, MCF-7 (estrogen receptor positive) and MDA-MB468 (estrogen receptor negative). Therefore, this study was aimed to investigate the expression and possible action of A3 receptor in the human breast cancer cell lines. IB-MECA, at 1-100 microM, resulted in a significant cell growth inhibition (P < 0.05) which reached the maximum at 48 h, in the cell lines. In both cell lines, agonist-induced effects were antagonized by pretreatment with a selective A3 adenosine receptor antagonist, MRS1220. Using RT-PCR method, further confirmation was provided by the presence of mRNA of A3 receptor in the cells. In addition, IB-MECA was able to inhibit forskolin-stimulated cAMP levels, which indicate the functional form of A3 receptor on the cell surface of these breast cancer cell lines. These results suggest that the inhibitory effect of IB-MECA on the growth of human breast cancer cell lines is mediated through activation of A3 adenosine receptor. |
| |
Keywords: | |
本文献已被 ScienceDirect PubMed 等数据库收录! |
|